Epigenome-wide association study and functional analyses reveal regulatory loci linked to lung function and diabetes in cystic fibrosis
Abstract
Background While the genetic basis of cystic fibrosis is well-established, the genotype alone does not explain the substantial inter-individual variability in disease expression, particularly in pulmonary outcomes. Non-hereditary factors, such as epigenetic modifications, may contribute to this clinical heterogeneity. Methods To investigate the clinical variability in cystic fibrosis, we profiled DNA methylation in 64 blood samples from the MethylCF cohort and conducted an epigenome-wide association study. DNA methylation levels were corrected for cell count heterogeneity. We analysed associations between DNA methylation levels and disease status, lung function, body mass index, and cystic fibrosis-related diabetes. Results Genes in the JAK/STAT pathway exhibited methylation changes and differential expression in patient blood samples. Differentially methylated regions were enriched for binding sites of interferon regulatory factor 1. Functional and in silico analyses of seven top-differentially methylated loci revealed regulatory roles for four regions associated with SOCS3 , RGS1 , ASPH , and LYN . Notably, methylation at cg02586212 ( RGS1 ) was associated with cystic fibrosis-related diabetes and genetically controlled by a methylation quantitative trait locus that explained 30% of DNA methylation variance in our cohort. Additionally, differentially methylated CpG sites at SOCS3 , SBNO2 , and RGS1 overlapped with those observed in chronic obstructive pulmonary disease and rheumatoid arthritis, suggesting shared systemic inflammatory mechanisms. Conclusions Our findings highlight the biological relevance of epigenetic modifications in cystic fibrosis and support systemic inflammation as a common driver of differential DNA methylation across inflammatory diseases. Trial registration The study is registered at clinical.gov under reference #NCT02884622.
Related
- The role of gene regulatory evolution in weapon diversification: Insights from comparative genomics, chromatin profiling, and functional analyses of BMP signaling in horned beetles
- Genome-wide association study identifies candidate loci and a functional regulatory variant associated with egg-production traits in Wenchang chickens
- Integrated Transcriptomic and Metabolomic Analyses Reveal Leaf Regulatory Mechanisms Underlying Low-Nitrogen Tolerance in Oat (Avena sativa L.)
- Integrative Genomic Analyses Identify Collagen Type XXI Alpha 1 Chain and ENPEP‐Fibroblast Growth Factor 5 Regulatory Pathways for Blood Pressure Variation in East Asian People
- Comprehensive transcriptome and proteome analyses reveal genotype-specific regulatory networks under drought stress in Maize
BibTeX
@article{valdes2026epigenomewide,
title = {{Epigenome-wide association study and functional analyses reveal regulatory loci linked to lung function and diabetes in cystic fibrosis}},
author = {Loréna Valdés and Jorg Tost and Isabelle Rivals and Davide Caimmi and Florence Busato and Enora Fremy and Laurent Mely and Sylvie Leroy and Marlène Murris and Mireille Claustres and Milena Magalhães and Isabelle Vachier and Raphaël Chiron and Albertina de Sario},
journal = {Respiratory Research},
year = {2026},
month = sep,
doi = {10.1186/s12931-026-03895-w},
url = {https://hal.science/hal-05787286v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Epigenome-wide association study and functional analyses reveal regulatory loci linked to lung function and diabetes in cystic fibrosis
AU - Loréna Valdés
AU - Jorg Tost
AU - Isabelle Rivals
AU - Davide Caimmi
AU - Florence Busato
AU - Enora Fremy
AU - Laurent Mely
AU - Sylvie Leroy
AU - Marlène Murris
AU - Mireille Claustres
AU - Milena Magalhães
AU - Isabelle Vachier
AU - Raphaël Chiron
AU - Albertina de Sario
PY - 2026
DA - 2026/09/23
JO - Respiratory Research
DO - 10.1186/s12931-026-03895-w
UR - https://hal.science/hal-05787286v1
AB - Background While the genetic basis of cystic fibrosis is well-established, the genotype alone does not explain the substantial inter-individual variability in disease expression, particularly in pulmonary outcomes. Non-hereditary factors, such as epigenetic modifications, may contribute to this clinical heterogeneity. Methods To investigate the clinical variability in cystic fibrosis, we profiled DNA methylation in 64 blood samples from the MethylCF cohort and conducted an epigenome-wide association study. DNA methylation levels were corrected for cell count heterogeneity. We analysed associations between DNA methylation levels and disease status, lung function, body mass index, and cystic fibrosis-related diabetes. Results Genes in the JAK/STAT pathway exhibited methylation changes and differential expression in patient blood samples. Differentially methylated regions were enriched for binding sites of interferon regulatory factor 1. Functional and in silico analyses of seven top-differentially methylated loci revealed regulatory roles for four regions associated with SOCS3 , RGS1 , ASPH , and LYN . Notably, methylation at cg02586212 ( RGS1 ) was associated with cystic fibrosis-related diabetes and genetically controlled by a methylation quantitative trait locus that explained 30% of DNA methylation variance in our cohort. Additionally, differentially methylated CpG sites at SOCS3 , SBNO2 , and RGS1 overlapped with those observed in chronic obstructive pulmonary disease and rheumatoid arthritis, suggesting shared systemic inflammatory mechanisms. Conclusions Our findings highlight the biological relevance of epigenetic modifications in cystic fibrosis and support systemic inflammation as a common driver of differential DNA methylation across inflammatory diseases. Trial registration The study is registered at clinical.gov under reference #NCT02884622.
SN - 1465-9921
ER -